Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-1440
    Keywords: Bone marrow transplantation ; Aplastic anaemia ; Acute leukaemia ; Chronic granulocytic leukaemia
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary From 1972–1983 53 patients underwent bone marrow transplantation. The median age was 18 years (3–41). 27 patients suffered from severe aplastic anaemia, 22 patients had acute leukaemia and 4 patients had chronic granulocytic leukaemia in chronic phase. Out of 22 patients with acute leukaemia, 2 had florid leukaemia, 2 had an early relapse and 18 patients were in first or second remission of their disease. 2/53 patients received a syngeneic transplant, 51/53 patients an allogeneic transplant. 47/51 patients had a HLA-A, B, C-identical, MLC-negative sibling donor, 1/51 had a HLA-A, B-C-identical, MLC-positive sibling donor, 2/51 a HLA-phaenotypical identical parental donor and 1/51 a HLA-identical, MLC-negative unrelated donor. The comparison of the results obtained in patients with severe aplastic anaemia transplanted from 1972–1979 with those transplanted from 1980–1983 shows that the bone marrow transplantation has to be performed in an early stage of the disease before the patients become multiple transfused, sensitized and severely infected and that the conditioning regimen for polytransfused patients has to be more intensive than in untransfused patients. From the patient group transplanted 1972–1979, only 1/14 patients is a long-term survivor in contrast to 8/13 patients transplanted from 1980–1983. 11/22 patients with acute leukaemia are alive between more than 5 years and 14 days after bone marrow transplantation. Only 1/4 patients, who were transplanted not in remission, is alive. For patients with acute leukaemia the bone marrow transplantation should be performed in an early stage of their disease when the tumor burden is small and when the patients are in good clinical condition. 2/4 patients with CGL are alive between 12 months and 3 months after bone marrow transplantation. In our patient group graft versus host disease was the most important problem with a high mortality due to GvHD associated infections.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-2102
    Keywords: Schlüsselwörter Morbus Hodgkin ; Non-Hodgkin ; Strahlentherapie ; Großfeldtechnik ; Key words Hodgkin's disease ; non-Hodgkin's disease ; Radiotherapy ; Large-field technique
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Summary The role of radiotherapy in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma has changed considerably in the last few decades. Clinical observation of mainly unicentric pathogenesis with continuous expansion and subclinical involvement of adjoining regions of lymph nodes has resulted in the introduction of a large-field technique with total nodal irradiation (TNI) or total lymphatic irradiation (TLI). The introduction of polychemotherapy has led to further improvement in the cure rate and in considerations concerning using both methods and adapting them to the stage and risk. Today the combination of radiation and chemotherapy leads to a reduction in the amount of radiation required in the affected regions (involved field irradiation = IFI).
    Notes: Zusammenfassung Die Rolle der Strahlentherapie hat bei der Behandlung des Morbus Hodgkin (MH) wie der Non-Hodgkin-Lymphome (NHL) in den letzten Jahrzehnten einen erheblichen Wandel erfahren. Die klinische Beobachtung der überwiegend unizentrischen Entstehung mit kontinuierlicher Ausbreitung und subklinischem Befall angrenzender Lymphknotenregionen hat zur Einführung der Großfeldtechnik bis hin zur „total nodalen Bestrahlung“ (TNI) bzw. „total lymphatischen Bestrahlung“ (TLI) geführt. Die Einführung der Polychemotherapie führte zur weiteren Verbesserung der Heilungsraten, jedoch auch zu Überlegungen im Hinblick auf einen stadien- und risikoadaptierten Einsatz beider Verfahren. So erfolgt heute bei Kombination der Strahlen- und Chemotherapie eine Reduktion der Bestrahlungvolumina auf die makroskopisch befallenen Regionen in Form der „involved field irradiation“ (IFI).
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...